This article is more than 5 years old. Information may no longer be current.
Thoracic Surgery Oncology Group names new member institution
Click Here to Manage Email Alerts
The American Association for Thoracic Surgery’s Thoracic Surgery Oncology Group has named NYU Langone Health as one of its 23 member institutions.
Established in 2017, Thoracic Surgery Oncology Group is a clinical trials network that recruits patients to thoracic surgeon-led phase 1/phase 2 studies, window-of-opportunity trials, intraoperative imaging studies, registry studies and multidisciplinary studies.
Membership in Thoracic Surgery Oncology Group will allow NYU Langone Health’s Perlmutter Cancer Center to have enhanced collaboration for its translational and clinical trial research.
To be eligible for inclusion in the group, centers must conduct a high volume of thoracic oncology procedures, especially for lung, esophageal and other thoracic malignancies. Centers also must demonstrate site-specific financial sustainability and have infrastructure for accrual to and completion of clinical trials led by thoracic surgeons.
“Over the last few years, Perlmutter Cancer Center has recruited some of the top surgical, medical, pulmonary and radiation oncologists in the country,” Harvey I. Pass, MD, division director of general thoracic surgery and surgical chief of thoracic oncology at NYU Langone’s Perlmutter Cancer Center, said in a press release. “Combined with our recent designation as a comprehensive cancer center by the NCI, selection as a member of the [Thoracic Surgery Oncology Group] highlights Perlmutter Cancer Center’s position as a major lung cancer center in the United States.”
Founding cancer centers of Thoracic Surgery Oncology Group include Brigham and Women’s Hospital, Duke University, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Centre Hospitalier de l’Université de Montréal, University of Pittsburgh, University of Toronto and Washington University in St. Louis.